FDA/FTC Issue Warning for Unapproved COVID Product
9/28/22 — The FDA issued a warning letter jointly with the Federal Trade Commission to Bespoke Apothecary LLC for selling unapproved and misbranded COVID kit and Post Virus Recovery Herbal Tea products as drugs for use in treating or preventing COVID-19.